(Q42396417)

English

RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

scientific article published on 4 July 2016

Statements

RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer (English)
1 reference
0 references
Laura B Pritzker
1 reference
Ken P H Pritzker
1 reference
Anthony O'Grady
1 reference
Robert Cummins
1 reference
Liam Grogan
1 reference
John Kennedy
1 reference
Elaine W Kay
1 reference
Norma O'Donovan
1 reference
Roshni Kalachand
1 reference
John Crown
1 reference
4 July 2016
1 reference
108
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit